206 related articles for article (PubMed ID: 36201260)
1.
Kitano A; Norikura T; Matsui-Yuasa I; Shimakawa H; Kamezawa M; Kojima-Yuasa A
J Med Food; 2022 Oct; 25(10):982-992. PubMed ID: 36201260
[TBL] [Abstract][Full Text] [Related]
2. Black carrot extract protects against hepatic injury through epigenetic modifications.
Kitano A; Norikura T; Matsui-Yuasa I; Shimakawa H; Kamezawa M; Kojima-Yuasa A
J Food Biochem; 2022 Oct; 46(10):e14292. PubMed ID: 35762419
[TBL] [Abstract][Full Text] [Related]
3. Ethanol metabolism and oxidative stress are required for unfolded protein response activation and steatosis in zebrafish with alcoholic liver disease.
Tsedensodnom O; Vacaru AM; Howarth DL; Yin C; Sadler KC
Dis Model Mech; 2013 Sep; 6(5):1213-26. PubMed ID: 23798569
[TBL] [Abstract][Full Text] [Related]
4. Hydroxytyrosol attenuates ethanol-induced liver injury by ameliorating steatosis, oxidative stress and hepatic inflammation by interfering STAT3/iNOS pathway.
Fang X; Cao J; Tao Z; Yang Z; Dai Y; Zhao L
Redox Rep; 2023 Dec; 28(1):2187564. PubMed ID: 36932927
[No Abstract] [Full Text] [Related]
5. CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis.
Abdelmegeed MA; Banerjee A; Jang S; Yoo SH; Yun JW; Gonzalez FJ; Keshavarzian A; Song BJ
Free Radic Biol Med; 2013 Dec; 65():1238-1245. PubMed ID: 24064383
[TBL] [Abstract][Full Text] [Related]
6. Ethanol metabolism by alcohol dehydrogenase or cytochrome P
Doody EE; Groebner JL; Walker JR; Frizol BM; Tuma DJ; Fernandez DJ; Tuma PL
Am J Physiol Gastrointest Liver Physiol; 2017 Dec; 313(6):G558-G569. PubMed ID: 28864499
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 2E1-dependent hepatic ethanol metabolism induces fatty acid-binding protein 4 and steatosis.
Attal N; Marrero E; Thompson KJ; McKillop IH
Alcohol Clin Exp Res; 2022 Jun; 46(6):928-940. PubMed ID: 35403271
[TBL] [Abstract][Full Text] [Related]
8. Ecklonia cava Polyphenol Has a Protective Effect against Ethanol-Induced Liver Injury in a Cyclic AMP-Dependent Manner.
Yamashita H; Goto M; Matsui-Yuasa I; Kojima-Yuasa A
Mar Drugs; 2015 Jun; 13(6):3877-91. PubMed ID: 26096275
[TBL] [Abstract][Full Text] [Related]
9. Aldehyde dehydrogenase 2 deficiency ameliorates alcoholic fatty liver but worsens liver inflammation and fibrosis in mice.
Kwon HJ; Won YS; Park O; Chang B; Duryee MJ; Thiele GE; Matsumoto A; Singh S; Abdelmegeed MA; Song BJ; Kawamoto T; Vasiliou V; Thiele GM; Gao B
Hepatology; 2014 Jul; 60(1):146-57. PubMed ID: 24492981
[TBL] [Abstract][Full Text] [Related]
10. Translational Implications of the Alcohol-Metabolizing Enzymes, Including Cytochrome P450-2E1, in Alcoholic and Nonalcoholic Liver Disease.
Song BJ; Akbar M; Jo I; Hardwick JP; Abdelmegeed MA
Adv Pharmacol; 2015; 74():303-72. PubMed ID: 26233911
[TBL] [Abstract][Full Text] [Related]
11. Effect of liver disorders on ethanol elimination and alcohol and aldehyde dehydrogenase activities in liver and erythrocytes.
Zorzano A; Ruiz del Arbol L; Herrera E
Clin Sci (Lond); 1989 Jan; 76(1):51-7. PubMed ID: 2920534
[TBL] [Abstract][Full Text] [Related]
12. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
13. Dietary tomato powder inhibits alcohol-induced hepatic injury by suppressing cytochrome p450 2E1 induction in rodent models.
Stice CP; Liu C; Aizawa K; Greenberg AS; Ausman LM; Wang XD
Arch Biochem Biophys; 2015 Apr; 572():81-88. PubMed ID: 25592162
[TBL] [Abstract][Full Text] [Related]
14. Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage.
Morgan K; French SW; Morgan TR
Hepatology; 2002 Jul; 36(1):122-34. PubMed ID: 12085356
[TBL] [Abstract][Full Text] [Related]
15. Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice.
Lu Y; Wu D; Wang X; Ward SC; Cederbaum AI
Free Radic Biol Med; 2010 Nov; 49(9):1406-16. PubMed ID: 20692331
[TBL] [Abstract][Full Text] [Related]
16. Effect of Clomethiazole Vs. Clorazepate on Hepatic Fat and Serum Transaminase Activities in Alcohol-Associated Liver Disease: Results from a Randomized, Controlled Phase II Clinical Trial.
Hohmann N; Schröder F; Moreira B; Teng H; Burhenne J; Bruckner T; Mueller S; Haefeli WE; Seitz HK
Alcohol Alcohol; 2023 Mar; 58(2):134-141. PubMed ID: 36562601
[TBL] [Abstract][Full Text] [Related]
17. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease.
Wu W; Zhu B; Peng X; Zhou M; Jia D; Gu J
Biochem Biophys Res Commun; 2014 Jan; 443(1):68-73. PubMed ID: 24269813
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol-induced steatosis.
Avila DV; Barker DF; Zhang J; McClain CJ; Barve S; Gobejishvili L
J Pathol; 2016 Sep; 240(1):96-107. PubMed ID: 27287961
[TBL] [Abstract][Full Text] [Related]
19. Chronic free-choice drinking in crossed high alcohol preferring mice leads to sustained blood ethanol levels and metabolic tolerance without evidence of liver damage.
Matson L; Liangpunsakul S; Crabb D; Buckingham A; Ross RA; Halcomb M; Grahame N
Alcohol Clin Exp Res; 2013 Feb; 37(2):194-201. PubMed ID: 22757960
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane ameliorates ethanol plus carbon tetrachloride-induced liver fibrosis in mice through the Nrf2-mediated antioxidant response and acetaldehyde metabolization with inhibition of the LPS/TLR4 signaling pathway.
Ishida K; Kaji K; Sato S; Ogawa H; Takagi H; Takaya H; Kawaratani H; Moriya K; Namisaki T; Akahane T; Yoshiji H
J Nutr Biochem; 2021 Mar; 89():108573. PubMed ID: 33388347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
